| Name | Hvivo |
|---|---|
| Epic | HVO |
| Isin | GB00B9275X97 |
| Industry | Medical Equipment and Services |
| Latest share price | 6.58p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £45.21 | Debt ratio | n/a |
| Shares in issue | 687.01 | Debt-to-equity ratio | n/a |
| P/E ratio | 12.1 | Assets / equity ratio | n/a |
| Total dividends per share | 0.20p | Price to book value | n/a |
| Dividend yield | 1 | ROCE | 23.85 |
| Dividend cover | 8.45 | EPS growth | 33 |
| Earning per share | 1.57 | 52-week high / low | 6.42p / 29.80p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2025-05-15 | 2025-06-11 | 0.20p |
| Final | 2024-04-18 | 2024-05-20 | 0.20p |
| Special | 2023-05-04 | 2023-06-09 | 0.45p |
| Company name | Hvivo |
|---|---|
| Address | Floor 24, 40 Bank Street, London, United Kingdom, E14 5NR |
| Telephone | |
| Website | http://hvivo.com/ |
| Director | Position |
|---|---|
| Mr Yamin Mo' Khan | CEO |
| Mr Brendan Buckley | Non-Executive Director |
| Mr Shaun Chilton | Non-Executive Chairman |
| Dr Elaine Sullivan | Senior Independent Director |
| Mr Stephen Pinkerton | CFO & Executive Director |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/12/24 | 31/12/23 | 31/12/22 |
| Intangible asssets and goodwill | 5.7 | 5.67 | 6.02 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 28.66 | 31.22 | 9.15 |
| Inventory / work in progress | 0.8 | 0.43 | 0.5 |
| Trade and other receivables | 15.24 | 14.6 | 13.29 |
| Cash and equivalents | 44.18 | 36.97 | 28.44 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 88.89 | 83.23 | 51.38 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 31.92 | 35.18 | 29.76 |
| Long term liabilities | 12.3 | 13.72 | 1.4 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 44.22 | 48.9 | 31.16 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 44.67 | 34.33 | 20.22 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 0.68 | 0.68 | 0.67 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 48.81 | 38.68 | 25.04 |
| Share premium account | 0.52 | 0.52 | n/a |
| Total equity | 44.67 | 34.33 | 20.22 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 12.86 | 10.1 | 6.02 |
| Pre-tax profit | 13.29 | 11.15 | -0.36 |